Mirabegron
NDC 70518-4631, Mirabegron, tablet, extended release, from REMEDYREPACK INC..
- Product NDC
- 70518-4631
- Status
- Listed
- Labeler
- REMEDYREPACK INC.
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA209488
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70518-4631 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MIRABEGRON25 mg/1
Pharmacologic classes
Adrenergic beta3-Agonists [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]; beta3-Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70518-4631-0 | 70518463100 | 50 POUCH in 1 BOX (70518-4631-0) / 1 TABLET, EXTENDED RELEASE in 1 POUCH (70518-4631-1) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/b71b939e-8cb1-492c-8311-28f75dc4c682
Use it
Look up 70518-4631 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70518-4631 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70518-4631. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.